GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Invuity Inc (NAS:IVTY) » Definitions » Earnings Yield (Joel Greenblatt) %

Invuity (Invuity) Earnings Yield (Joel Greenblatt) % : -32.05% (As of Jun. 2018)


View and export this data going back to 2015. Start your Free Trial

What is Invuity Earnings Yield (Joel Greenblatt) %?

Invuity's Enterprise Value for the quarter that ended in Jun. 2018 was $104.62 Mil. Invuity's EBIT for the trailing twelve months (TTM) ended in Jun. 2018 was $-33.54 Mil. Invuity's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2018 was -32.05%.

The historical rank and industry rank for Invuity's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

IVTY's Earnings Yield (Joel Greenblatt) % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.19
* Ranked among companies with meaningful Earnings Yield (Joel Greenblatt) % only.

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Invuity's Forward Rate of Return (Yacktman) % for the quarter that ended in Jun. 2018 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


Invuity Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for Invuity's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invuity Earnings Yield (Joel Greenblatt) % Chart

Invuity Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17
Earnings Yield (Joel Greenblatt) %
- - -41.32 -52.91 -31.15

Invuity Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.22 -24.88 -31.15 -52.36 -32.05

Competitive Comparison of Invuity's Earnings Yield (Joel Greenblatt) %

For the Medical Instruments & Supplies subindustry, Invuity's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invuity's Earnings Yield (Joel Greenblatt) % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Invuity's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Invuity's Earnings Yield (Joel Greenblatt) % falls into.



Invuity Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

Invuitys Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2017 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=-37.548/120.48466
=-31.16 %

Invuity's EBIT for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-33.54 Mil.



Invuity  (NAS:IVTY) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


Invuity Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Invuity's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Invuity (Invuity) Business Description

Traded in Other Exchanges
N/A
Address
Invuity Inc is a United States-based commercial-stage medical technology company which utilizes its proprietary Intelligent Photonics technology to develop single-use and reusable illuminated surgical devices. It provides surgeons with illumination and direct visualization of surgical cavities during open minimally invasive and minimal access procedures. Its products include Eikon Illuminated Retractor System, Saber Yankauer, Saber Frazier, Eika Illuminated Retractor System, Breiten Illuminated Retractor System, Eipex Illuminated Retractor System, Eivector Illuminated Retractor System, Waveguide XT System, among others. It sells directly to hospitals, surgeons typically drive the purchasing decision.
Executives
Gregory T Lucier director C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Eric W Roberts director VALENCE LIFE SCIENCES LLC, 500 PARK AVENUE 9TH FLOOR, NEW YORK NY 10022
William W Burke director 3868 MOCKINGBIRD LN, DALLAS TX 75205
Randall A Lipps director 1101 EAST MEADOW DR, PALO ALTO CA 94303
Dan Wolterman director 3721 VALLEY CENTRE DR, SUITE 500, SAN DIEGO CA 92130
James H Mackaness officer: Chief Financial Officer 1212 TERRA BELLA AVENUE, MOUNTAIN VIEW CA 94043
Reza Zadno director 2710 SAND HILL ROAD, SUITE 200, MENLO PARK CA 94025
James E Flynn 10 percent owner, other: Possible Member of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Management Company, L.p. (series C) 10 percent owner, other: Possible Member of 10% Group 345 PARK AVENUE SOUTH, 12TH FLOOR, NEW YORK NY 10010
Deerfield Mgmt L.p. 10 percent owner, other: Possible Member of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Deerfield Special Situations Fund, L.p. 10 percent owner, other: Possible Member of 10% Group 780 3RD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Douglas A Pepper 10 percent owner C/O INTERWEST PARTNERS, 2710 SAND HILL ROAD, SUITE 200, MENLO PARK CA 94025
Philip T Gianos 10 percent owner 2710 SAND HILL ROAD, SUITE 200, MENLO PARK CA 94025
Keval Desai 10 percent owner 467 FIRST STREET, SUITE 201, LOS ALTOS X1 94022
Interwest Partners X Lp 10 percent owner C/O INTERWEST PARTNERS, 467 FIRST STREET SUITE 201, LOS ALTOS CA 94022